A Case Report of Severe Coagulopathy in Antenatal COVID-19
- PMID: 36065377
- PMCID: PMC9440626
- DOI: 10.1155/2022/7777445
A Case Report of Severe Coagulopathy in Antenatal COVID-19
Abstract
Pregnancy is a naturally occurring hypercoagulable state, and COVID-19 can cause profound changes in the coagulation system associated with thromboinflammation. We report a case of a pregnant woman with moderate symptoms of COVID-19 and a severe coagulopathy with unexpected low levels of fibrinogen and factor VIII as well as atypical thrombelastometry results. She developed a severe placental dysfunction with intrauterine fetal distress and perinatal death. The case did not fulfil the criteria for preeclampsia or sepsis, and the adverse outcome was assessed as a direct effect of the COVID-19 infection with placental insufficiency, despite absence of serious maternal pulmonary symptoms. Atypical persistent coagulopathy may serve as an important marker of a serious obstetrical situation in COVID-19.
Copyright © 2022 Anna Sand et al.
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Poon L. C., Shennan A., Hyett J. A., et al. Erratum to “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention” [Int J Gynecol Obstet 145 Suppl. 1 (2019) 1–33] International Journal of Gynaecology and Obstetrics . 2019;146(3):390–391. doi: 10.1002/ijgo.12892. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources